NCT02250430View on ClinicalTrials.gov

A Phase 1 Study Assessing Local Cutaneous Effects of SB204

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions
Acne Vulgaris
Interventions
DRUG

SB204

Applied topically twice a day on days 1, 2 and 3 to left and right cheeks

Trial Locations (1)

19008

KGL, Broomall

All Listed Sponsors
lead

Novan, Inc.

INDUSTRY

NCT02250430 - A Phase 1 Study Assessing Local Cutaneous Effects of SB204 | Biotech Hunter | Biotech Hunter